AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 80.83 |
| Open | 80.31 |
| Bid | 79.98 x 700 |
| Ask | 80.05 x 700 |
| Day's range | 80.00 - 80.51 |
| 52-week range | 60.47 - 80.86 |
| Volume | |
| Avg. volume | 5,196,342 |
| Market cap | 248.103B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 39.42 |
| EPS (TTM) | 2.03 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 1.45 (1.79%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | 84.81 |
ZacksPharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Eli Lilly's (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Tagrisso.
ZacksAbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Data from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
Fool.co.ukI’d buy this FTSE 100 stock without hesitation
Finding the right investments can be a challenge, but I've found one FTSE 100 stock that ticks all the boxes for my long-term portfolio. The post I’d buy this FTSE 100 stock without hesitation appeared first on The Motley Fool UK.
© 2024 Yahoo. All rights reserved.